Clinical Trials Logo

Communicable Diseases clinical trials

View clinical trials related to Communicable Diseases.

Filter by:

NCT ID: NCT04435587 Recruiting - SARS-CoV2 Infection Clinical Trials

Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection

IDRA-COVID19
Start date: July 13, 2020
Phase: Phase 4
Study type: Interventional

This is an open label randomised controlled study of oral ivermectin (600 mcg/kg/d* 3 day) versus combined of hydroxychloroquine plus darunavir/ ritonavir for 5 days treatment among asymptomatic carrier of SAR-CoV2 adult Thai population. Both study treatment regimens will have oral zinc sulfate combination treatment ( 200mg. twice daily). Outcomes include safety and duration of detectable of SAR-CoV2 in nasopharyngeal/ throat (NP) swab by polymerase chain reaction amplification (PCR) after treatment. 40-50 patients in each treatment arm is planned, with an interim analysis when approximately 50% of cases is enrolled.

NCT ID: NCT04432233 Recruiting - Clinical trials for Helicobacter Pylori Infection

Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease

Start date: June 15, 2020
Phase: Phase 4
Study type: Interventional

Helicobacter pylori infection causes active peptic ulcer disease and related complications like bleeding and pyloric obstruction. Usually, clinicians tended to treat Helicobacter pylori infection after active peptic ulcer disease and related complicaitons getting healed, which spent time and money. This study is designed to evaluate the efficacy and safety of intravenous administration of metronidazole, levofloxacin and esomeprazole triple therapy in the treatment of Helicobacter pylori infection combined with peptic ulcer disease related complications.

NCT ID: NCT04431050 Recruiting - Clinical trials for Respiratory Syncytial Virus Infections

Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens

SIMPLIFI
Start date: February 24, 2020
Phase:
Study type: Observational

This study evaluates a single use point of care diagnostic test in the diagnosis of influenza and other respiratory viral infections in adults. Participants will have a sample taken from their nose using a swab. The swab will be gently mixed in a liquid solution which will then be transferred into the device for testing.

NCT ID: NCT04429594 Recruiting - Clinical trials for Coronavirus Infections

Study of the Incidence of SARS-CoV-2 Infection (COVID-19)

CovImmune 2
Start date: July 28, 2020
Phase: N/A
Study type: Interventional

This is a prospective observational cohort study that will define the prevalence and incidence of CA-SARS-Cov2 infection using serological and PCR tests in a group of subjects during deconfinement. The team wishes to include approximately 1000 subjects in this study. The health crisis through containment has also created unprecedented environmental conditions with the very clear decrease in economic activities and a consequent decrease in exposure to the main air pollutants. The aim is therefore to carry out a case-control study in which each subject will be his or her own control in unexposed condition (to PM2.5, PM10, NO...) then exposed (after the recovery of economic activity and the usual levels of air pollutants) and to measure the impact of these pollutants on the immune system and epigenetic markers taking into account seasonality. The occurrence of infectious, cardiovascular, allergic and autoimmune events will then be measured according to the immunological profiles measured at inclusion.

NCT ID: NCT04425122 Recruiting - Esophageal Cancer Clinical Trials

The Microbiome of Oesophageal Squamous Cell Carcinoma

Start date: July 1, 2020
Phase:
Study type: Observational

This is a prospective study on the microbiota associated with oesophageal squamous cell carcinoma (SCC). Patients with newly diagnosed SCC of oesophagus would be recruited for taking samples of oral and oesophageal rinse, tissue biopsies for investigation of the microbiota of oesophageal cancer. Control patients would be identified from patients scheduled for routine endoscopy.

NCT ID: NCT04423692 Recruiting - Viral Infection Clinical Trials

Knowledge About Covid-19 Infection in Pregnant Women

Start date: June 1, 2020
Phase:
Study type: Observational

Covid 19 is a pandemic infection developed in late 2019

NCT ID: NCT04422535 Recruiting - Clinical trials for Coronavirus Infection

Effects on the Qt Interval of COVID-19 Coronavirus Infection

QT-COVID-19
Start date: May 29, 2020
Phase:
Study type: Observational

The present study aims to evaluate the impact of COVID-19 disease and its treatment on ventricular repolarization, assessed by measuring the QTc interval, in patients admitted to the critical care unit.

NCT ID: NCT04416373 Recruiting - Breastfeeding Clinical Trials

COVID-19 and Pregnancy Outcomes

COVID&PREG
Start date: March 22, 2020
Phase:
Study type: Observational

This is a multicenter prospective study that aims to investigate the clinical impact of SARS-CoV-2 infection in pregnant women, pregnancy outcomes and perinatal transmission.

NCT ID: NCT04413565 Recruiting - Clinical trials for Arthroplasty Complications

Infection Rate of One-Stage Bilateral TKR - One Surgeon Sequential vs. Two Surgeon Simultaneous: A Randomized Controlled Study

Start date: December 8, 2016
Phase: N/A
Study type: Interventional

The use of bilateral total knee replacements (TKR) is increasing with the number of patients with bilateral end-stage knee osteoarthritis. Bilateral TKR can be performed in three different ways: single-stage, two-team simultaneous bilateral TKR (two surgeons bilateral TKR); single-stage, a sequential bilateral TKR (single surgeon bilateral TKR); and two-stage bilateral TKR. Periprosthetic joint (PJI) infections are serious complications after TKR that negatively affect the aimed outcome, decrease patient satisfaction, and increase morbidity and mortality. The incidence of PJI is 1-2% and the number of cases is projected to grow as the indications for TKR continue to increase. Investigators will prospectively compare the incidence of periprosthetic joint infection between groups.

NCT ID: NCT04413305 Recruiting - Clinical trials for Klebsiella Pneumoniae Infection

WGS-guided Tracking and Infection Control Measures of CRKP

Start date: May 28, 2020
Phase: N/A
Study type: Interventional

The objective of this study is to investigate the effect of the infection control measures based on the active screening of carbapenem-resistant Klebsiella pneumoniae and whole-genome based tracking and surveillance though the hospital.